Crohn’s Disease - Japan Drug Forecast and Market Analysis to 2022

Crohn’s Disease - Japan Drug Forecast and Market Analysis to 2022. The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market.